Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Thomson

Showing results (481-490 of 512) with videos related to

Pageof 52
Sort By:
European Journal of Nuclear Medicine|January 19, 2000
Contamination hazard due to iodine-131 therapy for thyrotoxicosisS F Barrington, M J O'Doherty, A G Kettle, et al.
European Journal of Nuclear Medicine|July 10, 1999
Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismS F Barrington, M J O'Doherty, A G Kettle, et al.
Journal of Affective Disorders|September 2, 2018
Differentiating responders and non-responders to rTMS treatment for depression after one week using resting EEG connectivity measuresN W Bailey, K E Hoy, N C Rogasch, et al.
African Journal of Thoracic and Critical Care Medicine|April 22, 2025
Computed tomography chest imaging for the detection of pulmonary hypertension in patients with post-tuberculosis lung diseaseM Almubarek, E H Louw, S Griffith-Richards, et al.
Biophysical Journal|December 4, 2003
The circularization of amyloid fibrils formed by apolipoprotein C-IIDanny M Hatters, Christopher A MacRaild, Rob Daniels, et al.
Angewandte Chemie (International Ed. in English)|February 24, 2005
Adsorption and self-assembly of peptides on mica substratesConor Whitehouse, Jiyu Fang, Amalia Aggeli, et al.
Clinical Pharmacology and Therapeutics|July 25, 2013
Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibodyM Reilly, R M Miller, M H Thomson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II CommitteeP A Vasey, S B Kaye, R Morrison, et al.
The Lancet. Healthy Longevity|September 18, 2022
Effectiveness and cost-effectiveness of oral nutritional supplements in frail older people who are malnourished or at risk of malnutrition: a systematic review and meta-analysisKatie H Thomson, Stephen Rice, Oluwatomi Arisa, et al.
Trials|March 22, 2026
Towards high-quality and timely interim analyses in adaptive trials: a scoping review of best practice and evidence gapsKatie H Thomson, Opeyemi Agbeleye, Chizoba Oparah, et al.
Pageof 52

Showing results (481-490 of 512) with videos related to

Sort By:
Pageof 52
European Journal of Nuclear Medicine|January 19, 2000
Contamination hazard due to iodine-131 therapy for thyrotoxicosisS F Barrington, M J O'Doherty, A G Kettle, et al.
European Journal of Nuclear Medicine|July 10, 1999
Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismS F Barrington, M J O'Doherty, A G Kettle, et al.
Journal of Affective Disorders|September 2, 2018
Differentiating responders and non-responders to rTMS treatment for depression after one week using resting EEG connectivity measuresN W Bailey, K E Hoy, N C Rogasch, et al.
African Journal of Thoracic and Critical Care Medicine|April 22, 2025
Computed tomography chest imaging for the detection of pulmonary hypertension in patients with post-tuberculosis lung diseaseM Almubarek, E H Louw, S Griffith-Richards, et al.
Biophysical Journal|December 4, 2003
The circularization of amyloid fibrils formed by apolipoprotein C-IIDanny M Hatters, Christopher A MacRaild, Rob Daniels, et al.
Angewandte Chemie (International Ed. in English)|February 24, 2005
Adsorption and self-assembly of peptides on mica substratesConor Whitehouse, Jiyu Fang, Amalia Aggeli, et al.
Clinical Pharmacology and Therapeutics|July 25, 2013
Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibodyM Reilly, R M Miller, M H Thomson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II CommitteeP A Vasey, S B Kaye, R Morrison, et al.
The Lancet. Healthy Longevity|September 18, 2022
Effectiveness and cost-effectiveness of oral nutritional supplements in frail older people who are malnourished or at risk of malnutrition: a systematic review and meta-analysisKatie H Thomson, Stephen Rice, Oluwatomi Arisa, et al.
Trials|March 22, 2026
Towards high-quality and timely interim analyses in adaptive trials: a scoping review of best practice and evidence gapsKatie H Thomson, Opeyemi Agbeleye, Chizoba Oparah, et al.
Pageof 52